drug
raxibacumab
Marketedupdated 5mo agoby $EBS Emergent BioSolutions Inc.
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying raxibacumab
News(1)
- Narcan maker Emergent BioSolutions eliminates top R&D role in sweeping restructuringTwo and a half years into his tenure as Emergent BioSolutions CEO, Joseph Papa is executing another round of restructuring to align the business with “current business realities.”fiercebiotech · 2mo ago
Data sources
last refreshed 2h ago
Found something off?
comments(0)
5-min edit window · permanent after that